GSTM1 and chronic kidney disease: Further, 1 observational study tracked 427 patients over 4 years, finding a baseline CKD prevalence of 21.4% in sickle cell anemia and 17.2% in Hb-Sβ+ thalassemia and Hb-SC SCD [2].